Panelists discuss how longer-acting treatments will enable extended intervals between visits while requiring careful adjustment of monitoring protocols and clinic workflows to balance reduced ...

Morning Glory Syndrome (MGS) is a rare and complex disease that necessitates a multidisciplinary approach for effective management and enhanced patient outcomes, according to Suping Wu, MD, and ...

OCU410 is a novel multifunctional modifier gene therapy candidate that targets multiple pathways associated with GA. Ocugen, Inc. completed dosing ahead of schedule in the Phase 2 portion of the Phase ...

Artificial intelligence (AI) is fast developing into an indispensable tool for managing patients with geography atrophy (GA) by facilitating individualized care. However, more refinements to the ...

The submission deadline for both the 2025 Jenny Pomeroy Award for Excellence in Vision and Public Health and the sixth annual Rising Visionary Award is Monday, March 10, 2025, at noon ET. Prevent ...

Intravitreal injections often feel overwhelming for patients and time-consuming for clinics. From scheduling frequent appointments to ensuring patients receive timely care, the complexity of the ...

The 2025 Snowmass Retina and Eye Meeting, taking place at the Viceroy Hotel from March 24–28 in Snowmass, Colorado, offers retina specialists an immersive learning experience alongside winter ...

“Our current understanding of the pathophysiological basis of MacTel has led to the development of novel therapeutic approaches that may be able to break ground in this disease state.” Macular ...

A recent study of AEYE-DS AI technology used in conjunction with the Topcon NW500 resulted in exceptional clinical diagnostic efficacy. AEYE Health and Topcon Healthcare, Inc., are sharing results of ...

Over the past several decades, vision researchers have recognized that cerebral/cortical visual impairment (CVI) is a leading cause of pediatric visual impairment in the US and other industrialized ...

A look at the current state of AI in diabetic eye disease and where the future may take us. Artificial intelligence (AI) and deep learning tools are now a part of many people’s daily lives, whether ...

Aurion Biotech, Inc. has appointed Donald Munoz as chief financial officer (CFO). Greg Kunst, Aurion’s CEO, commented on this news in the company’s press release 1, saying, “We are delighted to ...